A ligA three-domain region protects hamsters from lethal infection by leptospira interrogans

PLoS Neglected Tropical Diseases

Volumn 5, Issue 12, 2011, Pages

  Coutinho, Mariana L ^a,b   Choy, Henry A ^a,c   Kelley, Melissa M ^a   Matsunaga, James ^a,c   Babbitt, Jane T ^a,c   Lewis, Michael S ^a   Aleixo, Jose Antonio G ^b   Haake, David A ^a,c,d  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; RECOMBINANT LIGA PROTEIN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL VACCINE; LIVE VACCINE; RECOMBINANT PROTEIN; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL LOAD; BLOOD CHEMISTRY; CONTROLLED STUDY; COPENHAGEN RAT; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENE DOSAGE; HAMSTER; HISTOPATHOLOGY; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SEROTYPE; ANALYSIS OF VARIANCE; ANIMAL; BODY WEIGHT; CHEMISTRY; GENETICS; IMMUNOLOGY; KIDNEY; MICROBIOLOGY; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; SURVIVAL; SYRIAN HAMSTER;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; BODY WEIGHT; CRICETINAE; FEMALE; KIDNEY; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MESOCRICETUS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 84855265972     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001422     Document Type: Article

References (42)

1. Levett PN, (1997) Leptospirosis. In: Emmerson A, Hawkey P, Gillespie S, editors. Principles and Practice of Clinical Bacteriology Edinburgh pp. 677-690.
2. Hartskeerl RA, Collares-Pereira M, Ellis WA, (2011) Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect 17: 494-501.
3. WHO, (2003) Human leptospirosis: Guidance for diagnosis, surveillance and control. Geneva, Switzerland WHO.
4. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR, (2008) The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2: e300.
5. Reis RB, Ribeiro GS, Felzemburgh RD, Santana FS, Mohr S, et al. (2008) Impact of environment and social gradient on Leptospira infection in urban slums. PLoS Negl Trop Dis 2: e228.
6. Tucunduva de Faria M, Calderwood MS, Athanazio DA, McBride AJ, Hartskeerl RA, et al. (2008) Carriage of Leptospira interrogans among domestic rats from an urban setting highly endemic for leptospirosis in Brazil. Acta Trop 108: 1-5.
7. Haake DA, (2009) Spirochetes. In: Schaechter M, editors. Encyclopedia of Microbiology. 3rd ed Oxford Academic Press pp. 278-292.
8. Haake DA, Dundoo M, Cader R, Kubak BM, Hartskeerl RA, et al. (2002) Leptospirosis, water sports, and chemoprophylaxis. Clin Infect Dis 34: e40-43.
9. Stern EJ, Galloway R, Shadomy SV, Wannemuehler K, Atrubin D, et al. (2010) Outbreak of leptospirosis among adventure race participants in Florida, 2005. Clin Infect Dis 50: 843-849.
10. Ko AI, Galvao Reis M, Ribeiro Dourado CM, Johnson WD Jr, Riley LW, et al. (1999) Urban epidemic of severe leptospirosis in Brazil. Lancet 354: 820-825.
11. Bey RF, Johnson RC, (1986) Current status of leptospiral vaccines. Prog Vet Microbiol Immunol 2: 175-197.
12. Pinne M, Haake D, (2009) A comprehensive approach to identification of surface-exposed, outer membrane-spanning proteins of Leptospira interrogans. PLoS One 4: e6071.
13. Haake DA, Walker EM, Blanco DR, Bolin CA, Miller MN, et al. (1991) Changes in the surface of Leptospira interrogans serovar grippotyphosa during in vitro cultivation. Infect Immun 59: 1131-1140.
14. Cullen PA, Xu X, Matsunaga J, Sanchez Y, Ko AI, et al. (2005) Surfaceome of Leptospira spp. Infect Immun 73: 4853-4863.
15. Matsunaga J, Wernied K, Zuerner R, Frank A, Haake DA, (2006) LipL46 is a novel, surface-exposed lipoprotein expressed during leptospiral dissemination in the mammalian host. Microbiology 152: 3777-3786.
16. Haake DA, Matsunaga J, (2010) Leptospira: a spirochaete with a hybrid outer membrane. Mol Microbiol 77: 805-814.
17. Pinne M, Choy HA, Haake D, (2010) The OmpL37 surface-exposed protein is expressed by pathogenic Leptospira during infection and binds skin and vascular elastin. PLoS Negl Trop Dis 4: e815.
18. Haake DA, Chao G, Zuerner RL, Barnett JK, Barnett D, et al. (2000) The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun 68: 2276-2285.
19. Lucas DS, Cullen PA, Lo M, Srikram A, Sermswan RW, et al. (2011) Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. Vaccine 29: 3413-3418.
20. Seixas FK, da Silva EF, Hartwig DD, Cerqueira GM, Amaral M, et al. (2007) Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 26: 88-95.
21. Branger C, Chatrenet B, Gauvrit A, Aviat F, Aubert A, et al. (2005) Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1. Infect Immun 73: 4062-4069.
22. Branger C, Sonrier C, Chatrenet B, Klonjkowski B, Ruvoen-Clouet N, et al. (2001) Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect Immun 69: 6831-6838.
23. Haake DA, Mazel MK, McCoy AM, Milward F, Chao G, et al. (1999) Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun 67: 6572-6582.
24. Choy HA, Kelley MM, Chen TL, Moller AK, Matsunaga J, et al. (2007) Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect Immun 75: 2441-2450.
25. Choy HA, Kelley MM, Croda J, Matsunaga J, Babbitt JT, et al. (2011) The multifunctional LigB adhesin binds homeostatic proteins with potential roles in cutaneous infection by pathogenic Leptospira interrogans. PLoS ONE 6: e16879.
26. Croda J, Ramos JG, Matsunaga J, Queiroz A, Homma A, et al. (2007) Leptospira immunoglobulin-like proteins as a serodiagnostic marker for acute leptospirosis. J Clin Microbiol 45: 1528-1534.
27. Silva EF, Medeiros MA, McBride AJ, Matsunaga J, Esteves GS, et al. (2007) The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 25: 6277-6286.
28. Koizumi N, Watanabe H, (2004) Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine 22: 1545-1552.
29. Matsunaga J, Barocchi MA, Croda J, Young TA, Sanchez Y, et al. (2003) Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol 49: 929-945.
30. Matsunaga J, Medeiros MA, Sanchez Y, Werneid KF, Ko AI, (2007) Osmotic regulation of expression of two extracellular matrix-binding proteins and a haemolysin of Leptospira interrogans: differential effects on LigA and Sph2 extracellular release. Microbiology 153: 3390-3398.
31. Matsunaga J, Sanchez Y, Xu X, Haake DA, (2005) Osmolarity, a key environmental signal controlling expression of leptospiral proteins LigA and LigB and the extracellular release of LigA. Infect Immun 73: 70-78.
32. McBride AJ, Cerqueira GM, Suchard MA, Moreira AN, Zuerner RL, et al. (2009) Genetic diversity of the leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp. Infect Genet Evol 9: 196-205.
33. Lin YP, McDonough SP, Sharma Y, Chang YF, (2010) The terminal immunoglobulin-like repeats of LigA and LigB of Leptospira enhance their binding to gelatin binding domain of fibronectin and host cells. PLoS ONE 5: e11301.
34. Yan W, Faisal SM, McDonough SP, Divers TJ, Barr SC, et al. (2009) Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model. Microbes Infect 11: 230-237.
35. Faisal SM, Yan W, Chen CS, Palaniappan RU, McDonough SP, et al. (2008) Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Vaccine 26: 277-287.
36. Ellis WA, Thiermann AB, (1986) Isolation of Leptospira interrogans serovar bratislava from sows in Iowa. Am J Vet Res 47: 1458-1460.
37. Perkins FT, (1958) A ready reckoner for the calculation of geometric mean antibody titres. J Gen Microbiol 19: 540-541.
38. Faine S, (1982) Guidelines for the control of leptospirosis. Geneva World Health Organization.
39. Jeanpierre C, Whitmore SA, Austruy E, Cohen-Salmon M, Callen DF, et al. (1993) Chromosomal assignment of the uromodulin gene (UMOD) to 16p13.11. Cytogenet Cell Genet 62: 185-187.
40. Ren SX, Fu G, Jiang XG, Zeng R, Miao YG, et al. (2003) Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 422: 888-893.
41. Faisal SM, Yan W, Chen CS, Palaniappan RU, McDonough SP, et al. (2007) Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Vaccine 26: 277-287.
42. Goris MG, Wagenaar JF, Hartskeerl RA, van Gorp EC, Schuller S, et al. (2011) Potent innate immune response to pathogenic leptospira in human whole blood. PLoS ONE 6: e18279.